glp-1 and antidepressants Psychotropic effects of GLP-1R agonists Exploring the Side Effects of

doi: 10.1161/CIRCULATIONAHA.124.067676

Following this, the SURPASS-3 trial evaluated tirzepatide in patients with T2DM inadequately controlled by metformin, with or without SGLT2 inhibitors

GLP-1s have seen unparalleled launch success despite the controls in place in the market

Psychiatr Clin Neurosci

Every single morning, you need to measure your dose, hold it under your tongue for two to five minutes, and then wait 30 minutes before eating or drinking

The largest meta-analysis to date, comprising 13 cardiovascular outcome trials involving 83,258 patients with and without diabetes, confirmed that GLP-1 Ras significantly reduced major adverse cardiovascular events (MACEs), all-cause mortality, cardiovascular mortality, fatal and non-fatal strokes, coronary revascularization, and composite kidney outcomes [87]